Mary Ann Liebert, Inc., publishers

06/09/2025

In case you missed it: Michael Pollan’s latest article in The New Yorker, “This Is Your Priest on Drugs,” explores an extraordinary Johns Hopkins study on psilocybin’s impact on spiritual leadership.

We’re proud this study was published in Psychedelic Medicine, reinforcing the journal’s leadership at the intersection of science, spirituality, and mental health.

📖 Read the feature: https://hubs.li/Q03rkbC20
🔬 Read the study: https://hubs.li/Q03rk92b0

A sincere thank you to Editors-in-Chief Dr. Peter Hendricks and Dr. Charles Nichols for their visionary leadership.

Dozens of religious leaders experienced magic mushrooms in a university study. Many are now evangelists for psychedelics.

06/09/2025

🧠 Insights from the Experts
Join global leaders in gene editing—including Dr. Feng Zhang—at The State of CRISPR and Gene Editing 2025 virtual summit. Hear about the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash its full potential in the clinic and beyond.
🗓️ Date: June 11, 2025
🕒 Time: 11:00 AM - 3:30 PM (ET)
🔗 Register Now for FREE: https://hubs.ly/Q03rgZfH0

06/06/2025

New Open-Access Resource for Acupuncture Researchers

The Topological Atlas and Repository for Acupoint Research (TARA) is an innovative new database that allows scientists to deposit, share, and compare data on acupuncture points. Developed with funding from the National Center for Complementary and Integrative Health, TARA is poised to advance our understanding of acupoint mechanisms.

In Medical Acupuncture, Dr. Helene Langevin highlights how TARA can support data synthesis across disciplines and shed light on how stimulation of the body’s surface affects internal systems like the interstitium and nervous system.

📖 Read the article: https://hubs.li/Q03r8kG-0

06/04/2025

Register now for the State of CRISPR & Genome Editing virtual summit, hosted by GEN, happening on June 11th! Closing the summit, Beth Shapiro PhD, Chief Scientific Officer at Colossal Biosciences, will give an exclusive in-depth interview discussing ancient DNA, the de-extinction debate, and Colossal's claims regarding the use of multiplex genome editing to create 'dire wolf' cubs.

To register for this free event, visit:
https://hubs.li/Q03qHw150

06/03/2025

Unlock the Future of Healthcare!

Join us for an exclusive webinar, "Tails of Innovation: Transforming RNA Therapeutics with Cutting-Edge Poly(A) Modifications." 🧬

🗓️ TODAY: Tuesday, June 3rd, 2025
⏰ Time: 8:00 am PT | 11:00 am ET | 17:00 CET

Hosted by TriLink BioTechnologies and Mary Ann Liebert, Inc., this is your opportunity to dive into revolutionary genetic engineering breakthroughs with leading experts. Curious about how these innovations could change the face of healthcare? Don’t wait—reserve your spot now! REGISTER NOW: https://hubs.li/Q03jDx1G0

06/02/2025

🧠 A major step forward in brain injury research

When someone experiences a traumatic brain injury (TBI)—whether from a fall, accident, or sports injury—health professionals often struggle to consistently describe and classify what’s happening in the brain.

The National Institute of Neurological Disorders and Stroke (NINDS) has just launched a new initiative to change that. Their TBI Classification and Nomenclature Initiative, published in Journal of Neurotrauma, introduces a standardized way to define and categorize acute TBIs.

This new system helps researchers and clinicians speak the same language, improving how we study TBI and how we care for patients in the future.

📘 Read more:
https://hubs.li/Q03qbCTS0

06/02/2025

Be sure to register for The State of CRISPR and Genome Editing virtual summit from
GEN, coming up on June 11! Hear from the impressive 4-hour line-up that includes:
🔹Feng Zhang (Broad Institute of MIT and Harvard)
🔹Fyodor Urnov (Innovative Genomics Institute) on CRISPR Cures
🔹Alexis Komor and Nicole M. Gaudelli on the origins and future of base editing
🔹Neville Sanjana (New York Genome Center)
🔹Julie Makani and Johnny Mahlangu on the democratization of CRISPR and gene therapy
🔹Plus, a lively discussion with Beth Shapiro (Colossal Biosciences) on de-extinction and the dire wolf drama.

It's all free on June 11, register NOW:

It has been 20 years since the term “genome editing” first entered the scientific lexicon. The technology was transformed by the development of CRISPR gene editing in 2012. But the remarkable pace of progress in the first decade has hit some headwinds of late. In particular, the use of CRISPR as...

05/29/2025

Calling All Biotech Innovators!
DON'T MISS OUT!
Join us for an exclusive webinar: "Tails of Innovation: Transforming RNA Therapeutics with Cutting-Edge Poly(A) Modifications."

🗓️ Mark Your Calendar: Tuesday, June 3rd, 2025
⏰ Time: 8:00 am PT | 11:00 am ET | 16:00 CET

Brought to you by TriLink BioTechnologies and Mary Ann Liebert, Inc., this is your chance to explore groundbreaking genetic engineering breakthroughs with top industry experts. Ready to see how these advancements could revolutionize healthcare? Secure your spot today! REGISTER NOW https://hubs.li/Q03jDCXY0

05/21/2025

✨ New Special Issue Call for Papers – Health Equity Journal

We're thrilled to announce a new special issue on “Reimagining Perinatal Care to Promote Health Equity” in Health Equity, led by Editor-in-Chief Dr. Monica R. McLemore.

This issue centers radical reimaginings of wellness and justice across the lifespan for pregnant-capable people and their communities. Submissions may include original articles, poetry, podcasts, and visual art.

🌟 Rolling deadline through September 1, 2025
📥 Open to first-time authors and community-based voices
🔗 Learn more and submit: https://hubs.li/Q03nx5-j0

Tag someone whose voice belongs in this issue!

05/16/2025

Thank you to everyone who stopped by booth #1350 at ! It was a fantastic week connecting with the gene and cell therapy community. We loved sharing what’s new from Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., publishers, and Inside Precision Medicine. See you at the next event!

05/14/2025

A packed room at the Annual Meeting general sessions!

Joseph McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, spoke during the Presidential Symposium about advancing equitable, curative interventions for HIV and sickle cell disease. Among the most compelling developments: a potential one-pill HIV cure currently in progress.

Incredible insights from a leader in global health innovation.

05/13/2025

Attending the 2025 Annual Meeting in New Orleans?

Stop by Booth #1350 to connect with the teams from Mary Ann Liebert, Inc., publishers, Genetic Engineering & Biotechnology News, and Inside Precision Medicine!

We’re excited to share the latest issues of Human Gene Therapy, GEN, The CRISPR Journal, and more. Don’t miss your chance to meet the editors, learn about our newest content, and take home your favorite publications.